Activation of sterol regulatory element-binding proteins (SREBPs) is critical in IL-8-induced angiogenesis

Journal of Leukocyte Biology

Volumn 80, Issue 3, 2006, Pages 608-620

  Yao, Min ^a   Zhou, Rui Hai ^b   Petreaca, Melissa ^a   Zheng, Lei ^a   Shyy, John ^b   Martins Green, Manuela ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

bFGF; Cytokines; Neovascularization; Thrombin; VEGF

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; GUANOSINE TRIPHOSPHATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; INTERLEUKIN 8; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; THROMBIN; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MEMBRANE PERMEABILITY; CELL MIGRATION; CELL PROLIFERATION; CHORIOALLANTOIS; ENDOTHELIUM CELL; ENZYME REGULATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INFLAMMATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PLASMID VECTOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; ENDOTHELIAL CELLS; FIBROBLAST GROWTH FACTOR 2; HUMANS; INTERLEUKIN-8; NEOVASCULARIZATION, PHYSIOLOGIC; RHOA GTP-BINDING PROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEINS; THROMBIN; TIME FACTORS; TRANSCRIPTION FACTORS;

ORYCTOLAGUS CUNICULUS;

EID: 33751501966     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0304175     Document Type: Article

References (45)

1. Grob, P. M., David, E., Warren, T. C., DeLeon, R. P., Farina, P. R., Homon, C. A. (1990) Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J. Biol. Chem. 265, 8311-8316.
2. Rot, A. (1991) Chemotactic potency of recombinant human neutrophil attractant/activation protein-1 (interleukin-8) for polymorphonuclear leukocytes of different species. Cytokine 3, 21-27.
3. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., Strieter, R. M. (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-1801.
4. Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., Elner, S. G. (1992) Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol. 141, 1279-1284.
5. Hu, D. E., Hori, Y., Fan, T. P. (1993) Interleukin-8 stimulates angiogenesis in rats. Inflammation 17, 135-143.
6. Murdoch, C., Monk, P. N., Finn, A. (1999) CXC chemokine receptor expression on human endothelial cells. Cytokine 11, 704-712.
7. Li, A., Dubey, S., Varney, M. L., Dave, B. J., Singh, R. K. (2003) IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J. Immunol. 170, 3369-3376.
8. Martins-Green, M., Bissell, M. J. (1990) Localization of 9E3/CEF-4 in avian tissues: expression is absent in Rous sarcoma virus-induced tumors but is stimulated by injury. J. Cell Biol. 110, 581-595.
9. Inoue, K., Slaton, J. W., Eve, B. Y., Kim, S. J., Perrotte, P., Balbay, M. D., Yano, S., Bar-Eli, M., Radinsky, R., Pettaway, C. A., Dinney, C. P. (2000) Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin. Cancer Res. 6, 2104-2119.
10. Huang, S., Mills, L., Mian, B., Tellez, C., McCarty, M., Yang, X. D., Gudas, J. M., Bar-Eli, M. (2002) Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am. J. Pathol. 161, 125-134.
11. Zhou, R. H., Yao, M., Lee, T. S., Zhu, Y., Martins-Green, M., Shyy, J. Y. (2004) Vascular endothelial growth factor activation of sterol regulatory element binding protein: a potential role in angiogenesis. Circ. Res. 95, 471-478.
12. Horton, J. D., Shimomura, I. (1999) Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr. Opin. Lipidol. 10, 143-150.
13. Horton, J. D., Goldstein, J. L., Brown, M. S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131.
14. Brown, M. S., Ye, J., Rawson, R. B., Goldstein, J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391-398.
15. Horton, J. D., Shimomura, I., Brown, M. S., Hammer, R. E., Goldstein, J. L., Shimano, H. (1998) Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2. J. Clin. Invest. 101, 2331-2339.
16. Pai, J. T., Guryev, O., Brown, M. S., Goldstein, J. L. (1998) Differential stimulation of cholesterol and unsaturated fatty acid biosynthesis in cells expressing individual nuclear sterol regulatory element-binding proteins. J. Biol. Chem. 273, 26138-26148.
17. Brown, M. S., Goldstein, J. L. (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl. Acad. Sci. USA 96, 11041-11048.
18. Nohturfft, A., Brown, M. S., Goldstein, J. L. (1998) Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain. J. Biol. Chem. 273, 17243-17250.
19. Rawson, R. B. (2003) The SREBP pathway-insights from Insigs and insects. Nat. Rev. Mol. Cell Biol. 4, 631-640.
20. Coughlin, S. R. (2000) Thrombin signaling and protease-activated receptors. Nature 407, 258-264.
21. Chen, C. H., Poucher, S. M., Lu, J., Henry, P. D. (2004) Fibroblast growth factor 2: from laboratory evidence to clinical application. Curr. Vasc. Pharmacol. 2, 33-43.
22. Tomanek, R. J., Zheng, W., Yue, X. (2004) Growth factor activation in myocardial vascularization: therapeutic implications. Mol. Cell. Biochem. 264, 3-11.
23. Zeng, L., Lu, M., Mori, K., Luo, S., Lee, A. S., Zhu, Y., Shyy, J. Y. (2004) ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 23, 950-958.
24. Del Pozo, M. A., Vicente-Manzanares, M., Tejedor, R., Serrador, J. M., Sanchez-Madrid, F. (1999) Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes. Eur. J. Immunol. 29, 3609-3620.
25. Martins-Green, M., Kelly, T. (1998) The chicken chemotactic and angiogenic factor (9E3 gene product): its angiogenic properties reside in the C-terminus of the molecule. Cytokine 10, 819-830.
26. Feugate, J. E., Li, Q., Wong, L., Martins-Green, M. (2002) The CXC chemokine cCAF stimulates differentiation of fibroblasts into myofibroblasts and accelerates wound closure. J. Cell Biol. 156, 161-172.
27. Li, Q. J., Yao, M., Wong, W., Parpura, V., Martins-Green, M. (2004) The N- and C-terminal peptides of hIL8/CXCL8 are ligands for hCXCR1 and hCXCR2. FASEB J. 18, 776-778.
28. Nohturfft, A., Hua, X., Brown, M. S., Goldstein, J. L. (1996) Recurrent G-to-A substitution in a single codon of SREBP cleavage-activating protein causes sterol resistance in three mutant Chinese hamster ovary cell lines. Proc. Natl. Acad. Sci. USA 93, 13709-13714.
29. Espenshade, P. J., Cheng, D., Goldstein, J. L., Brown, M. S. (1999) Autocatalytic processing of site-1 protease removes propeptide and permits cleavage of sterol regulatory element-binding proteins. J. Biol. Chem. 274, 22795-22804.
30. Martins-Green, M., Feugate, J. E. (1998) The 9E3/CEF4 gene product is a chemotactic and angiogenic factor that can initiate the wound-healing cascade in vivo. Cytokine 10, 522-535.
31. Vaingankar, S. M., Martins-Green, M. (1998) Thrombin activation of the 9E3/CEF4 chemokine involves tyrosine kinases including c-src and the epidermal growth factor receptor. J. Biol. Chem. 273, 5226-5234.
32. Schraufstatter, I. U., Chung, J., Burger, M. (2001) IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1094-L1103.
33. Mo, H., Elson, C. E. (2004) Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. (Maywood) 229, 567-585.
34. Henning, S. W., Galandrini, R., Hall, A., Cantrell, D. A. (1997) The GTPase Rho has a critical regulatory role in thymus development. EMBO J. 16, 2397-2407.
35. Vu, T. K., Hung, D. T., Wheaton, V. I., Coughlin, S. R. (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64, 1057-1068.
36. Vasanji, A., Ghosh, P. K., Graham, L. M., Eppell, S. J., Fox, P. L. (2004) Polarization of plasma membrane microviscosity during endothelial cell migration. Dev. Cell 6, 29-41.
37. Ghosh, P. K., Vasanji, A., Murugesan, G., Eppell, S. J., Graham, L. M., Fox, P. L. (2002) Membrane microviscosity regulates endothelial cell motility. Nat. Cell Biol. 4, 894-900.
38. Carbajal, J. M., Schaeffer Jr., R. C. (1999) RhoA inactivation enhances endothelial barrier function. Am. J. Physiol. 277, C955-C964.
39. Van Nieuw Amerongen, G. P., Koolwijk, P., Versteilen, A., van Hinsbergh, V. W. (2003) Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler. Thromb. Vasc. Biol. 23, 211-217.
40. Essler, M., Linder, S., Schell, B., Hufner, K., Wiedemann, A., Randhahn, K., Staddon, J. M., Aepfelbacher, M. (2003) Cytotoxic necrotizing factor 1 of Escherichia coli stimulates Rho/Rho-kinase-dependent myosin light-chain phosphorylation without inactivating myosin light-chain phosphatase in endothelial cells. Infect. Immun. 71, 5188-5193.
41. Vincent, L., Soria, C., Mirshahi, F., Opolon, P., Mishal, Z., Vannier, J. P., Soria, J., Hong, L. (2002) Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, inhibits endothelial cell proliferation induced by angiogenic factors in vitro and angiogenesis in in vivo models. Arterioscler. Thromb. Vasc. Biol. 22, 623-629.
42. Takemoto, M., Liao, J. K. (2001) Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. Arterioscler. Thromb. Vasc. Biol. 21, 1712-1719.
43. Park, H. J., Kong, D., Iruela-Arispe, L., Begley, U., Tang, D., Galper, J. B. (2002) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors interfere with angiogenesis by inhibiting the geranylgeranylation of RhoA. Circ. Res. 91, 143-150.
44. Dooley, K. A., Bennett, M. K., Osborne, T. F. (1999) A critical role for cAMP response element-binding protein (CREB) as a co-activator in sterol-regulated transcription of 3-hydroxy-3-methylglutaryl coenzyme A synthase promoter. J. Biol. Chem. 274, 5285-5291.
45. Dooley, K. A., Millinder, S., Osborne, T. F. (1998) Sterol regulation of 3-hydroxy-3-methylglutaryl-coenzyme A synthase gene through a direct interaction between sterol regulatory element binding protein and the trimeric CCAAT-binding factor/nuclear factor Y. J. Biol. Chem. 273, 1349-1356.